EWVC x EIC
This edition highlights six women founders who are transforming cutting-edge research into innovative companies tackling some of today's biggest healthcare, industrial and environmental challenges. Supported through the European Innovation Council ecosystem, they are demonstrating how scientific excellence can become globally competitive businesses with real-world impact.
Together with the EIC Women Leadership Programme, we are proud to share the stories of entrepreneurs who are advancing deep-tech innovation while shaping the future of European leadership.
Read more about their stories → Here
SINDREL MedTech is developing a graphene-based, digitally controlled drug delivery platform that releases medication only when needed, enabling more precise and personalized treatment for epilepsy and other neurological conditions. Co-founder and CEO Audrey Franceschi Biagioni, a neuroscientist and entrepreneur, is leading the company's mission to translate breakthrough research into next-generation therapies.
MASAP develops modular aquaponics systems that combine fish farming and crop cultivation in a closed-loop ecosystem, enabling sustainable food production while significantly reducing water consumption. Co-founder and CFO Ligia Iuga-Roman combines expertise in finance and operations to scale climate innovation that supports more resilient agriculture.
Progressio.ai performs automated evidence-based conformity assessments, enabling organisations to continuously validate their conformance posture as AI systems, technical documentation and regulatory guidance evolve. Co-founder Margaret Hartnett, an award-winning intellectual property expert and AI researcher, is building the evidence infrastructure for AI governance at scale.
Bitteiler develops AI-powered data compression technology that enables IoT sensors to transmit more data while consuming fewer resources, making connected systems more efficient and sustainable. Co-founder and CTO Maroua Taghouti combines expertise in communication networks and artificial intelligence to advance the future of Industrial IoT.
Batea oncology is developing GlioHook, the first mecanomedicine for glioblastoma treatment. GlioHook is an implantable medical device designed to capture residual brain tumour cells and improve the effectiveness of radiotherapy following surgery. Co-founder and CEO Sonia Martínez Arca combines scientific expertise with biotechnology leadership to advance new treatment options for low Survival cancer.
CellFlow has developed a portable lab-on-chip platform that isolates target blood cells directly from whole blood, simplifying sample preparation for diagnostics and regenerative medicine. Co-founder and Chief Scientific Officer Yonca Belce is using her deep-tech expertise in materials science and microfluidics to bring next-generation healthcare technologies to market.
You can support us!
We are a community-founded organization, built from the ground up by people who believed in our cause and came together to make it happen.